These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8582046)

  • 41. Pharmacological characterization of Ro 63-1908 (1-[2-(4-hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a novel subtype-selective N-methyl-D-aspartate antagonist.
    Gill R; Alanine A; Bourson A; Buttelmann B; Fischer G; Heitz MP; Kew JN; Levet-Trafit B; Lorez HP; Malherbe P; Miss MT; Mutel V; Pinard E; Roever S; Schmitt M; Trube G; Wybrecht R; Wyler R; Kemp JA
    J Pharmacol Exp Ther; 2002 Sep; 302(3):940-8. PubMed ID: 12183650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NMDA-NR2B subtype selectivity of stereoisomeric 2-(1,2,3,4-tetrahydro-1-isoquinolyl)ethanol derivatives.
    Höfner G; Hoesl CE; Parsons C; Quack G; Wanner KT
    Bioorg Med Chem Lett; 2005 May; 15(9):2231-4. PubMed ID: 15837299
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro and in vivo antagonistic activities of SM-31900 for the NMDA receptor glycine-binding site.
    Ohtani K; Tanaka H; Yoneda Y; Yasuda H; Ito A; Nagata R; Nakamura M
    Brain Res; 2002 Jul; 944(1-2):165-73. PubMed ID: 12106676
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structure-activity relationships in a series of 2(1H)-quinolones bearing different acidic function in the 3-position: 6,7-dichloro-2(1H)-oxoquinoline-3-phosphonic acid, a new potent and selective AMPA/kainate antagonist with neuroprotective properties.
    Desos P; Lepagnol JM; Morain P; Lestage P; Cordi AA
    J Med Chem; 1996 Jan; 39(1):197-206. PubMed ID: 8568808
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Derivatives of dexanabinol. II. Salts of amino acid esters containing tertiary and quaternary heterocyclic nitrogen with increased water-solubility.
    Pop E; Soti F; Brewster ME; Barenholz Y; Korablyov V; Mechoulam R; Nadler V; Biegon A
    Pharm Res; 1996 Mar; 13(3):469-75. PubMed ID: 8692744
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anticonvulsant effects of phencynonate hydrochloride and other anticholinergic drugs in soman poisoning: neurochemical mechanisms.
    Wang YA; Zhou WX; Li JX; Liu YQ; Yue YJ; Zheng JQ; Liu KL; Ruan JX
    Life Sci; 2005 Nov; 78(2):210-23. PubMed ID: 16154160
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The anticonvulsant activity and cerebral protection of chronic lithium chloride via NMDA receptor/nitric oxide and phospho-ERK.
    Mohammad Jafari R; Ghahremani MH; Rahimi N; Shadboorestan A; Rashidian A; Esmaeili J; Ejtemaei Mehr S; Dehpour AR
    Brain Res Bull; 2018 Mar; 137():1-9. PubMed ID: 29102713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuroprotective actions of 2-amino-N-(1,2-diphenylethyl)-acetamide hydrochloride (FPL 13950) in animal models of hypoxia and global ischemia.
    Palmer GC; Cregan EC; Borrelli AR; Harris EW; Stagnitto ML; Colombo P; Kaiser FC; Murray RJ; Griffith RC; Strand JC
    J Pharmacol Exp Ther; 1995 Aug; 274(2):991-1000. PubMed ID: 7636764
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors.
    Masuko T; Namiki R; Nemoto Y; Miyake M; Kizawa Y; Suzuki T; Kashiwagi K; Igarashi K; Kusama T
    J Pharmacol Exp Ther; 2009 Nov; 331(2):522-30. PubMed ID: 19644042
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis, resolution, stereochemistry, and molecular modeling of (R)- and (S)-2-acetyl-1-(4'-chlorophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline AMPAR antagonists.
    Gitto R; Ficarra R; Stancanelli R; Guardo M; De Luca L; Barreca ML; Pagano B; Rotondo A; Bruno G; Russo E; De Sarro G; Chimirri A
    Bioorg Med Chem; 2007 Aug; 15(16):5417-23. PubMed ID: 17566746
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Solution-phase parallel synthesis and evaluation of anticonvulsant activity of N-substituted-3,4-dihydroisoquinoline-2(1H)-carboxamides.
    Gitto R; Pagano B; Citraro R; Scicchitano F; De Sarro G; Chimirri A
    Eur J Med Chem; 2009 Mar; 44(3):1349-54. PubMed ID: 18406016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH
    Gunia-Krzyżak A; Żelaszczyk D; Rapacz A; Żesławska E; Waszkielewicz AM; Pańczyk K; Słoczyńska K; Pękala E; Nitek W; Filipek B; Marona H
    Bioorg Med Chem; 2017 Jan; 25(2):471-482. PubMed ID: 27876250
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and structure-active relationship of 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline anticonvulsants.
    Gitto R; De Luca L; Ferro S; Agnello S; Russo E; De Sarro G; Chimirri A
    Chem Pharm Bull (Tokyo); 2010 Dec; 58(12):1602-5. PubMed ID: 21139262
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Deep prepiriform cortex modulates neuronal cell death in global ischemia.
    Kawaguchi K; Simon RP
    J Cereb Blood Flow Metab; 1997 Mar; 17(3):356-60. PubMed ID: 9119908
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design, synthesis, SAR, and biological evaluation of highly potent benzimidazole-spaced phosphono-alpha-amino acid competitive NMDA antagonists of the AP-6 type.
    Baudy RB; Fletcher H; Yardley JP; Zaleska MM; Bramlett DR; Tasse RP; Kowal DM; Katz AH; Moyer JA; Abou-Gharbia M
    J Med Chem; 2001 May; 44(10):1516-29. PubMed ID: 11334562
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuroprotective interaction effects of NMDA and AMPA receptor antagonists in an in vitro model of cerebral ischemia.
    Arias RL; Tasse JR; Bowlby MR
    Brain Res; 1999 Jan; 816(2):299-308. PubMed ID: 9878799
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MK-801 analogues: molecular properties required for recognition by the N-methyl-D-aspartate receptor.
    Leeson PD; James K; Carling RW; Wong EH; Baker R
    Prog Clin Biol Res; 1990; 361():513-8. PubMed ID: 2149766
    [No Abstract]   [Full Text] [Related]  

  • 58. Synthesis and evaluation of pharmacological profile of 1-aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamides.
    Gitto R; Ferro S; Agnello S; De Luca L; De Sarro G; Russo E; Vullo D; Supuran CT; Chimirri A
    Bioorg Med Chem; 2009 May; 17(10):3659-64. PubMed ID: 19398204
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The search for selective blockers of NMDA and AMPA/kainate receptors in a series of bis-ammonium compounds with adamantyl radicals].
    Gmiro VE; Serdiuk SE
    Eksp Klin Farmakol; 2000; 63(1):7-13. PubMed ID: 10763102
    [TBL] [Abstract][Full Text] [Related]  

  • 60. (1S,2R)-1-Phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC), a new class of NMDA-receptor antagonist: molecular design by a novel conformational restriction strategy.
    Shuto S; Yoshii K; Matsuda A
    Jpn J Pharmacol; 2001 Mar; 85(3):207-13. PubMed ID: 11325012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.